연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Hematology
Yufeng Shang has not added Biography.
If you are Yufeng Shang and would like to personalize this page please email our Author Liaison for assistance.
Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer.
Frontiers in oncology , 2019 | Pubmed ID: 31616632
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
Aging 10, 2019 | Pubmed ID: 31631064
Scoring systems for predicting mortality for severe patients with COVID-19.
EClinicalMedicine Jul, 2020 | Pubmed ID: 32766541
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study.
Virulence 12, 2020 | Pubmed ID: 33172355
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
Journal of medical virology 02, 2021 | Pubmed ID: 33289107
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
Frontiers in immunology , 2021 | Pubmed ID: 33936026
Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.
Frontiers in cell and developmental biology , 2021 | Pubmed ID: 34012958
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.
Journal of medical virology 04, 2022 | Pubmed ID: 34850404
Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
Hematological oncology Apr, 2022 | Pubmed ID: 34860428
Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency.
Frontiers in medicine , 2021 | Pubmed ID: 35004735
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.
Frontiers in oncology , 2022 | Pubmed ID: 35372017
zhongnan hospital of Wuhan University
Yalan Yu*,1,
Hui Shen*,1,
Li Liu1,
Ping Luo1,
Sanyun Wu1,
Jing He1,2,
Xiqin Tong1,
Yufeng Shang1,
Liang Shao1,
Fuling Zhou1
1Department of Hematology, Zhongnan Hospital of Wuhan University,
2Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유